Cargando…
Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma
CONTEXT: Aaptamine is a potent ocean-derived non-traditional drug candidate against human cancers. However, the underlying molecular mechanisms governing aaptamine-mediated repression of lung cancer cells remain largely undefined. OBJECTIVE: To examine the inhibitory effect of aaptamine on prolifera...
Autores principales: | Gong, Kaikai, Miao, Shuang, Yang, Lijuan, Wu, Yan, Guo, Jiwei, Chen, Weiwei, Dai, Juanjuan, Du, Jing, Xi, Sichuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580566/ https://www.ncbi.nlm.nih.gov/pubmed/33027592 http://dx.doi.org/10.1080/13880209.2020.1822420 |
Ejemplares similares
-
Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment
por: Du, Jing, et al.
Publicado: (2017) -
Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment
por: Du, Jing, et al.
Publicado: (2020) -
The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by
downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer
cells
por: Guo, Jiwei, et al.
Publicado: (2018) -
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2018) -
Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses
cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant
non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
por: Guo, Jiwei, et al.
Publicado: (2021)